As of June 03, 2025, CRISPR Therapeutics (CRSP) has a market cap of $3.29 billion USD. According to our data, CRISPR Therapeutics is ranked No.3345 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jun 03, 2025 | $3.29 B |
-3.35%
|
Dec 31, 2024 | $3.40 B |
-37.12%
|
Dec 29, 2023 | $5.41 B |
54.00%
|
Dec 30, 2022 | $3.51 B |
-46.36%
|
Dec 31, 2021 | $6.54 B |
-50.51%
|
Dec 31, 2020 | $13.22 B |
151.39%
|
Dec 31, 2019 | $5.26 B |
113.18%
|
Dec 31, 2018 | $2.47 B |
21.68%
|
Dec 29, 2017 | $2.03 B |
15.89%
|
Dec 30, 2016 | $1.75 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Editas Medicine
EDIT
|
$0.15 B |
-0.000 M
|
![]() USA
|
![]() Intellia Therapeutics
NTLA
|
$0.79 B |
-0.000 M
|
![]() USA
|
![]() Beam Therapeutics
BEAM
|
$1.69 B |
0.000 M
|
![]() USA
|
![]() Sangamo Therapeutics
SGMO
|
$0.12 B |
-0.000 M
|
![]() USA
|
![]() bluebird bio
BLUE
|
$48.67 M |
0.000 M
|
![]() USA
|
![]() REGENXBIO
RGNX
|
$0.51 B |
0.000 M
|
![]() USA
|
![]() CRISPR Therapeutics
CRSP
|
$3.29 B |
0.000 M
|
![]() Switzerland
|
![]() Vertex Pharmaceuticals
VRTX
|
$114.65 B |
0.000 M
|
![]() USA
|
![]() Moderna
MRNA
|
$10.76 B |
-0.000 M
|
![]() USA
|
![]() BioNTech
BNTX
|
$27.80 B |
0.001 M
|
![]() Germany
|
![]() Pfizer
PFE
|
$132.75 B |
0.003 M
|
![]() USA
|
![]() Novartis
NVS
|
$228.99 B |
-0.002 M
|
![]() Switzerland
|
![]() Regeneron Pharmaceuticals
REGN
|
$52.67 B |
0.886 B
|
![]() USA
|
![]() Amgen
AMGN
|
$155.70 B |
-0.000 M
|
![]() USA
|
![]() Gilead Sciences
GILD
|
$136.00 B |
-0.002 M
|
![]() USA
|
Market Cap | = | CRSP Stock Price | * | CRSP Shares Outstanding |
= | $38.04 | * | 86.36 M | |
= | $3.29 B |